These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


447 related items for PubMed ID: 31972657

  • 1. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part II. Pharmacodynamics of Electroencephalogram Effects.
    Eisenried A, Schüttler J, Lerch M, Ihmsen H, Jeleazcov C.
    Anesthesiology; 2020 Apr; 132(4):652-666. PubMed ID: 31972657
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
    Schüttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H.
    Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
    [Abstract] [Full Text] [Related]

  • 3. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR, Kilpatrick GJ, Tilbrook GS, Borkett KM.
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [Abstract] [Full Text] [Related]

  • 4. Comparative Analysis of the Performance of Electroencephalogram Parameters for Monitoring the Depth of Sedation During Remimazolam Target-Controlled Infusion.
    Bae MI, Bae J, Song Y, Kim M, Han DW.
    Anesth Analg; 2024 Jun 01; 138(6):1295-1303. PubMed ID: 38051672
    [Abstract] [Full Text] [Related]

  • 5. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM.
    Anesth Analg; 2012 Aug 01; 115(2):274-83. PubMed ID: 22190555
    [Abstract] [Full Text] [Related]

  • 6. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.
    Chen X, Sang N, Song K, Zhong W, Wang H, Jiang J, Huang Y, Hu P.
    Clin Ther; 2020 Apr 01; 42(4):614-624. PubMed ID: 32178858
    [Abstract] [Full Text] [Related]

  • 7. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers.
    Sheng XY, Liang Y, Yang XY, Li LE, Ye X, Zhao X, Cui YM.
    Eur J Clin Pharmacol; 2020 Mar 01; 76(3):383-391. PubMed ID: 31873765
    [Abstract] [Full Text] [Related]

  • 8. Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy.
    Pastis NJ, Yarmus LB, Schippers F, Ostroff R, Chen A, Akulian J, Wahidi M, Shojaee S, Tanner NT, Callahan SP, Feldman G, Lorch DG, Ndukwu I, Pritchett MA, Silvestri GA, PAION Investigators.
    Chest; 2019 Jan 01; 155(1):137-146. PubMed ID: 30292760
    [Abstract] [Full Text] [Related]

  • 9. Target-controlled Infusion of Remimazolam in Healthy Volunteers Shows Some Acute Tolerance.
    Vellinga R, Koomen JV, Eleveld DJ, Stöhr T, Pesic M, Struys MMRF, Colin PJ.
    Anesthesiology; 2024 Feb 01; 140(2):207-219. PubMed ID: 37889844
    [Abstract] [Full Text] [Related]

  • 10. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.
    Pambianco DJ, Borkett KM, Riff DS, Winkle PJ, Schwartz HI, Melson TI, Wilhelm-Ogunbiyi K.
    Gastrointest Endosc; 2016 May 01; 83(5):984-92. PubMed ID: 26363333
    [Abstract] [Full Text] [Related]

  • 11. Comparison emergence of sedation, using dexmedetomidine and remimazolam, in spinal anaesthesia - double blinded randomized controlled trial.
    Hong SW, Park JY, Rhee KY, Kim SH.
    Int J Med Sci; 2024 May 01; 21(8):1552-1558. PubMed ID: 38903925
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A miniature pig model of pharmacological tolerance to long-term sedation with the intravenous benzodiazepines; midazolam and remimazolam.
    Io T, Saunders R, Pesic M, Petersen KU, Stoehr T.
    Eur J Pharmacol; 2021 Apr 05; 896():173886. PubMed ID: 33493482
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prediction of depth of sedation and anaesthesia by the Narcotrend EEG monitor.
    Bauerle K, Greim CA, Schroth M, Geisselbrecht M, Köbler A, Roewer N.
    Br J Anaesth; 2004 Jun 05; 92(6):841-5. PubMed ID: 15064250
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects.
    Zhou J, Leonowens C, Ivaturi VD, Lohmer LL, Curd L, Ossig J, Schippers F, Petersen KU, Stoehr T, Schmith V.
    J Clin Anesth; 2020 Nov 05; 66():109899. PubMed ID: 32585566
    [Abstract] [Full Text] [Related]

  • 19. Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia.
    Lohmer LL, Schippers F, Petersen KU, Stoehr T, Schmith VD.
    J Clin Pharmacol; 2020 Apr 05; 60(4):505-514. PubMed ID: 31989598
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.